mainly that this info will typically be for treatments that have gone straight from phase 1 to phase 2. here (old tis) have already completed a phase 2 open label trial which the new trial is designed upon.
Some random thoughts on valuation..., page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
